| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/13/1997 | US5629454 Conformationally locked nucleoside analogues |
| 05/13/1997 | US5629431 Inhibitors of retroviral proteases |
| 05/13/1997 | US5629430 Anticarcinogenic agents |
| 05/13/1997 | US5629413 Oligonucleotides with activity against human immunodeficiency virus |
| 05/13/1997 | US5629406 Amino acid derivatives |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629312 Reducing neuron damage caused by gp-120 protein in aids patients |
| 05/13/1997 | US5629306 B-lactamase inhibitors |
| 05/13/1997 | US5629297 Administering ranitidine bismuth citrate and helicobacter inhibiting antibiotics |
| 05/13/1997 | US5629296 Bactericides, antibiotics |
| 05/13/1997 | US5629290 Cyclic peptide antifungal agents |
| 05/13/1997 | US5629289 Cyclic peptide antifungal agents |
| 05/13/1997 | US5629288 Lipopeptide derivatives, a process for their preparation and their use |
| 05/13/1997 | US5629282 Antibacterial compositions |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016456A1 Novel nucleoside derivatives and process for preparing the same |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016405A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 05/09/1997 | WO1997016204A1 Continuous low-dose cytokine infusion therapy |
| 05/07/1997 | EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines |
| 05/07/1997 | EP0771803A1 Pyrazolo(1,5-a)pyrimidinium substituted cephem derivatives, their preparation and their use as antimicrobial agents |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771322A1 Abundant extracellular products and methods for their production and use |
| 05/07/1997 | EP0771214A1 Treatment and prevention of helicobacter infection |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 05/07/1997 | EP0771199A1 Methods |
| 05/07/1997 | EP0771191A1 Immunological activity of rhamnolipids |
| 05/07/1997 | EP0771188A2 Soap composition |
| 05/07/1997 | EP0681578B1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 05/07/1997 | EP0667780A4 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents. |
| 05/07/1997 | EP0652957B1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | CN1149296A Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149254A Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 05/07/1997 | CN1149253A Use of N-alkyl derivatives of 1,5-dideoxy-1,5-imino-D-glucitol for the treatment of hepatitis B virus infections |
| 05/07/1997 | CN1148986A New skin preparation composition |
| 05/07/1997 | CN1034810C 1,3-oxathiolane nucleoside analogues |
| 05/07/1997 | CN1034805C Preparation of amino acid derivatives |
| 05/06/1997 | USH1649 HIV protease inhibitor combinations |
| 05/06/1997 | US5627215 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
| 05/06/1997 | US5627181 6-membered nitrogen-containing heteroaryl-oxazolidinones |
| 05/06/1997 | US5627163 Treatment of traveller's diarrhea |
| 05/06/1997 | US5627160 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
| 05/06/1997 | US5627153 Anti-fungal methods and materials |
| 05/06/1997 | US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 05/06/1997 | US5626850 Non-shedding live herpesvirus vaccine |
| 05/05/1997 | WO1997017353A1 Process for the preparation of 3-halogenocephem derivatives |
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770677A2 Improved sustainable chicken cell line for the production of Marek's disease vaccines |
| 05/02/1997 | EP0770622A2 Cyclic adhesion inhibitors |
| 05/02/1997 | EP0770609A1 Antiviral agent containing benzodithiin derivative as active ingredient |
| 05/02/1997 | EP0770606A1 Cis-epoxide derivate useful as irreversible HIV protease inhibitor and process for its preparation |
| 05/02/1997 | EP0770397A1 Newcastle disease virus combination vaccine |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770092A1 $i(HELICOBACTER PYLORI) NICKEL BINDING PROTEIN |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0770079A1 Heterobicyclic derivatives |
| 05/02/1997 | EP0770074A1 Anti-helicobacter acyl derivatives of azolones |
| 05/02/1997 | EP0770073A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 05/02/1997 | EP0770071A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 05/02/1997 | EP0769966A1 Biotin compounds for targetting tumors and sites of infection |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/02/1997 | EP0642525B1 Nucleosides being O-acylated with a mono-unsaturated omega-9 C18 or C20 fatty acid |
| 05/02/1997 | EP0627006B1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
| 05/02/1997 | EP0623024B1 Pharmaceutical bacteriocin compositions and their use for treating gastrointestinal disorders |
| 05/02/1997 | EP0590024B1 Topical composition enhancing healing of herpes lesions |
| 05/02/1997 | EP0544760B1 Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 05/02/1997 | EP0500917B1 Recombinant herpes simplex viruses vaccines and methods |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015579A1 Production of a crystalline salt of amoxicillin |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015320A1 Novel uses of mammalian ctla-8 and related reagents |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235495A1 Methods of preserving microorganisms |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148596A Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]-6-amino-3-azabicyclo[3,1,0]hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl |
| 04/30/1997 | CN1034714C Beads having a core coated with an antifungal and a polymer |
| 04/29/1997 | US5625050 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| 04/29/1997 | US5625034 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/29/1997 | US5624951 4-hydroxy coumarin derivatives with antibacterial activity |
| 04/29/1997 | US5624945 Use of riluzole for the treatment of neuro-aids |
| 04/29/1997 | US5624934 Protease inhibitors |
| 04/29/1997 | US5624842 Strain of Streptomyces for the production of tricyclo compounds |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |